ACUTE MYELOGENOUS LEUKEMIA (AML OR ANLL)

Clinical trials for ACUTE MYELOGENOUS LEUKEMIA (AML OR ANLL) explained in plain language.

Never miss a new study

Get alerted when new ACUTE MYELOGENOUS LEUKEMIA (AML OR ANLL) trials appear

Sign up with your email to follow new studies for ACUTE MYELOGENOUS LEUKEMIA (AML OR ANLL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Massive trial opens lifeline with unapproved cord blood for desperate patients

Disease control Recruiting now

This study provides access to cord blood units that are not yet FDA-approved for patients who need a transplant for blood cancers or other serious blood/immune disorders. It aims to see how well patients' immune systems recover after receiving these transplants and to monitor for…

Matched conditions: ACUTE MYELOGENOUS LEUKEMIA (AML OR ANLL)

Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

ACUTE MYELOGENOUS LEUKEMIA (AML OR ANLL)

Get alerted when new ACUTE MYELOGENOUS LEUKEMIA (AML OR ANLL) trials appear

Massive trial opens lifeline with unapproved cord blood for desperate patients